Trader consensus for no new pandemic in 2026, reflected in the 94.5% implied probability, stems primarily from current surveillance data showing no novel pathogen with sustained human-to-human transmission or pandemic potential. CDC and WHO monitoring through August 2026 indicates moderate global risk from circulating SARS-CoV-2 variants and seasonal respiratory viruses, alongside limited regional outbreaks such as Bundibugyo virus in the DRC and a contained May hantavirus cluster. High population immunity, improved clinical management, and established genomic surveillance reduce the likelihood of rapid escalation. Realistic challenges include undetected zoonotic spillovers, accelerated viral evolution in animal reservoirs, or an unforeseen Disease X event that could overwhelm early detection systems before the year ends.